Urothelial Cancer
A Phase 3, Randomized, Open-label Study of Sacituzumab Tirumotecan (MK-2870) Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced/Metastatic Urothelial Carcinoma (MK2870-031)
- Details
ClinicalTrials.gov ID:
NCT07419295
Diagnosis Type:
NA
USOR Number:
- Address
,
P: